Biologics, Inc. Secures Over $29 Million in Copay Assistance for Cancer Patients in 2014

Biologics, Inc. is pleased to announce that its Patient Access Services team secured over $29 million in copay assistance for patients diagnosed with cancer in 2014.

One in four of Biologics’ patients request financial assistance to help them afford their medications. Due to the high costs associated with many cancer drugs, patients are often put through a financial strain during the course of their treatment.

To alleviate this financial burden, Biologics screens individuals for patient assistance program eligibility, provides copay assistance counseling and manages enrollment. The team also works directly with charitable organizations, foundations and drug manufactures’ assistance programs.

Throughout treatment, the Patient Access Services team continues to monitor the patient’s out-of-pocket costs and copay assistance balance so that any potential issues are resolved before they arise.

“Our team is relentless in their pursuit of finding the necessary financial resources for our patients,” said Amanda Coakley Ulm, Director, Patient Access Services at Biologics. “I’m proud of our team’s effort in helping to alleviate this financial burden and to ensure our patients receive these important therapies.”

About Biologics, Inc.

Biologics, Inc. is a complex care management company that empowers healthcare providers, payors and biopharma to optimize complex care for the best possible outcomes – clinical, financial and emotional. Unifying fragmented healthcare services, Biologics brings efficiency and humanity to complex care management by focusing on the patient’s best interest as the surest path to managing cost and risk. Biologics is at the center of a rapidly changing healthcare environment and supports patients across all treatment modalities, while providing clinical outcomes and informatics reporting that allow for informed decision making. Privately held, Biologics maintains headquarters and operations in Cary, North Carolina. Visit biologicsinc.com or follow us on Twitter (@BiologicsInc).

Contacts:

Biologics, Inc.
Allison Keenan, 919-459-4922
Director of Marketing & Communications

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.